Tag: Iih treatment

According to the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) published in 2014, adding acetazolamide to a weight-reduction diet resulted in greater improvements in visual function for patients with mild vision loss than diet alone. This evidence solidified the role of acetazolamide as the most commonly used pharmaceutical to treat IIH (Idiopathic Intracranial Hypertension) by reducing cerebrospinal fluid (CSF) production. The treatment of IIH often involves a combination of medical management, weight loss, and, in severe cases, surgical intervention.

According to the landmark Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), a combination of acetazolamide and a low-sodium weight-reduction diet resulted in modestly significant visual field improvements for patients with mild visual loss. This makes acetazolamide a cornerstone of medical therapy for IIH.